Exploring New Frontiers in Blood Cancer Treatment

Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky 

Guest: Dr. Gregory Monohan, MD,  Professor, Division of Hematology and Blood Marrow Transplant, UK Markey Cancer Center

Cancer Conversations Episode 62

Dive into the latest episode of Cancer Conversation on Talking FACS, where host Mindy McCulley from the University of Kentucky Family and Consumer Sciences Extension is joined by Dr. Gregory Monohan, a professor of medicine in the Division of Hematology and Blood Marrow Transplant. In this insightful discussion, they explore groundbreaking advancements in the diagnosis and treatment of blood cancers, including leukemias, lymphomas, and multiple myeloma.

Dr. Monohan sheds light on the complexities of blood cancer classifications and the significant progress made in developing targeted therapies tailored to various subtypes. The episode highlights the pivotal role of immunotherapy, introducing CAR-T therapy, bispecific antibodies, and TIL therapy as cutting-edge approaches revolutionizing patient outcomes.

Listeners will gain a deeper understanding of the risk factors, symptoms, and innovative treatment methods that leverage the body's immune system to combat blood cancers. Whether you are a patient, a caregiver or simply curious about the latest cancer treatments, this episode offers valuable insights into the evolving landscape of blood cancer care.

Connect with the UK Markey Center

Online Markey Cancer Center

On Facebook @UKMarkey

On Twitter @UKMarkey